Clinical subtyping reveals significant differences in calcium-dependent phospholipase A2 activity in schizophrenia

Biological Psychiatry

Volumn 46, Issue 3, 1999, Pages 401-405

  Hudson, Craig ^a   Gotowiec, Andrew ^b   Seeman, Mary ^b   Warsh, Jerry ^b   Ross, Brian M ^b  

^a Stratford General Hospital Foundation   (Canada)

^b CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

Author keywords

Dopamine; Phospholipase A2; Phospholipids; Prostaglandins; Schizophrenia; Subtypes

Indexed keywords

NEUROLEPTIC AGENT; NICOTINIC ACID; PHOSPHOLIPASE A2;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE CLASSIFICATION; DRUG SENSITIVITY; ENZYME ACTIVITY; FEMALE; FLUSHING; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PHOSPHOLIPID METABOLISM; PRIORITY JOURNAL; RADIOMETRY; SCHIZOPHRENIA; VASODILATATION;

ADULT; ANTIPSYCHOTIC AGENTS; ARACHIDONIC ACID; CALCIUM; CALMODULIN; CHLORPROMAZINE; ENZYME ACTIVATION; FEMALE; HUMANS; MALE; NIACIN; PHOSPHOLIPASES A; SCHIZOPHRENIA; SECOND MESSENGER SYSTEMS;

EID: 0032806761     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(99)00010-4     Document Type: Article

References (24)

1. 2 activity in serum of neuroleptic-naive psychiatric inpatients. Pharmacopsychiatry. 26:1993;94-98.
2. th edition rev. 1994;Hogrefe and Huber Publishers, Toronto.
3. 2 activity in Epstein-Barr virus transformed lymphoblast cells from schizophrenic patients. Biol Psychiatry. 29:1991;1058-1062.
4. Chio C.L., Drong R.E., Riley D.T., Gill G.S., Slightom J.L., Huff R.M. D4 dopamine receptor-mediated signaling events determined in transfected Chinese hamster ovary cells. J Biol Chem. 269:1994;11813-11819.
5. Cochran C.D., Hale W.D. College student norms on the brief symptom inventory. J Clin Psychol. 41:1985;777-779.
6. 2 activity in schizophrenic patients Reduction after neuroleptic therapy . Biol Psychiatry. 22:(4):1987;421-426.
7. 2 activity in schizophrenia A replication study . Biol Psychiatry. 28:(6):1990;495-501.
8. Glen A.I.M. Niacin skin flush as a marker for a subgroup of schizophrenia patients. Am J Medical Genetics. 74:1997;597-598.
9. Hoppmann R.A., Peden J.G., Over S.K. Central nervous system side effects of nonsteroidal anti-inflammatory drugs. Arch Intern Med. 151:1991;1309-1313.
10. 2 associated with schizophrenia. Schizophr Res. 21:1996;111-116.
11. Hudson C.J., Lin A., Cogan S., Cashman F., Warsh J.J. The niacin challenge test Clinical manifestation of altered transmembrane signal transduction in schizophrenia? Biol Psychiatry. 41:1996;507-513.
12. Hudson C., Young T., Li P., Warsh J. CNS signal transduction in the pathophysiology and pharmacotherapy of affective disorders and schizophrenia. Synapse. 13:1993;278-293.
13. McAllister G., Knowles M.R., Patel S., Marwood R., Emms F., Seabrook G.R., et al. Characterization of a chimeric D3/D2 dopamine receptor expressed in CHO cells. FEBS Letts. 324:1993;81-86.
14. Morrow J.D., Awad J.A., Oates J.A., Roberts L.J. Identification of skin as a major site of prostaglandin D2 release following oral administration of niacin in humans. J Invest Dermatol. 98:1992;812-815.
15. Nielsen J.A., Sparber S.B. Indomethacin potentiates the operant behavior suppressant and rectal temperature lowering effects of low doses of d-amphetamine in rats. Pharm Biochem Behav. 21:1984;219-224.
16. 2 activity in schizophrenics and other psychiatric patients. Biol Psychiatry. 34:1993;641-649.
17. 2 gene with schizophrenia. Psychiatric Genetics. 8:1998;191-192.
18. 2 . Arch Gen Psych. 54:1997;487-494.
19. 2 activity is selectively decreased in the striatum of chronic cocaine users. J Neurochem. 67:1997;2620-2623.
20. Schwarz R.D., Uretsky N.J., Bianchine J.R. Prostaglandin inhibition of apomorphine induced circling in mice. Pharm Biochem Behav. 17:1982;1233-1237.
21. Schwarz R.D., Uretsky N.J., Bianchine J.R. Prostaglandin inhibition of amphetamine-induced circling in mice. Psychopharm. 78:1982;317-321.
22. Spitzer R.L., Williams J.B.W., Gibbons M. Structured Clinical Interview for DSM-III-R (SCID). 1986;New York State Psychiatric Institute, Biometric Research, New York.
23. 2. J Neurochem. 64:1995;2765-2772.
24. Wilken J. Chlorpropamide-alcohol flushing, malar thermal circulation index, and baseline malar temperature. Metabolism. 31:1982;948-954.